VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis

VEGF-B, a homolog of VEGF discovered a long time ago, has not been considered an important target in antiangiogenic therapy. Instead, it has received little attention from the field. In this study, using different animal models and multiple types of vascular cells, we revealed that although VEGF-B i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhang, Fan, Tang, Zhongshu, Hou, Xu, Lennartsson, Johan, Li, Yang, Koch, Alexander W., Scotney, Pierre, Lee, Chunsik, Arjunan, Pachiappan, Dong, Lijin, Kumar, Anil, Rissanen, Tuomas T., Wang, Bin, Nagai, Nobuo, Fons, Pierre, Fariss, Robert, Zhang, Yongqing, Wawrousek, Eric, Tansey, Ginger, Raber, James, Fong, Guo-Hua, Ding, Hao, Greenberg, David A., Becker, Kevin G., Herbert, Jean-Marc, Nash, Andrew, Yla-Herttuala, Seppo, Cao, Yihai, Watts, Ryan J., Li, Xuri
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2009
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2669337/
https://ncbi.nlm.nih.gov/pubmed/19369214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0813061106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados